BACKGROUND: Transvenous pacemaker and defibrillator lead extraction is a higher risk procedure with variation in preferred technique. A frequently fatal complication of this procedure is perforation of the superior vena cava. We have developed a tandem femoral-superior technique that incorporates snaring of targeted leads from a femoral approach combined with use of a rotational cutting sheath advanced over the lead from the subclavian vein. OBJECTIVE: We sought to evaluate the safety and efficacy of a tandem femoral-superior approach to lead extraction. METHODS: Consecutive patients undergoing transvenous extraction of at least 1 pacemaker or defibrillator lead with implant duration ≥1 year in which a tandem femoral-superior technique was used as the initial extraction strategy were included. The registry spanned 2010-2018 and consisted of procedures performed by a single primary operator. RESULTS: A total of 131 patients were included. A total of 267 leads with a mean implant duration of 9.8 years, including 90 defibrillator leads (33.7%), were targeted for extraction. No superior vena cava perforation or other vascular damage occurred. Clinical procedural success was achieved in 96.2% of cases. There were 5 major complications (3.8% of patients), with 3 being pericardial effusion requiring intervention. There were no deaths. CONCLUSION: A tandem femoral-superior approach to lead extraction effectively eliminated superior vena cava injury. This is a safe and effective technique for transvenous lead extraction.
BACKGROUND: Transvenous pacemaker and defibrillator lead extraction is a higher risk procedure with variation in preferred technique. A frequently fatal complication of this procedure is perforation of the superior vena cava. We have developed a tandem femoral-superior technique that incorporates snaring of targeted leads from a femoral approach combined with use of a rotational cutting sheath advanced over the lead from the subclavian vein. OBJECTIVE: We sought to evaluate the safety and efficacy of a tandem femoral-superior approach to lead extraction. METHODS: Consecutive patients undergoing transvenous extraction of at least 1 pacemaker or defibrillator lead with implant duration ≥1 year in which a tandem femoral-superior technique was used as the initial extraction strategy were included. The registry spanned 2010-2018 and consisted of procedures performed by a single primary operator. RESULTS: A total of 131 patients were included. A total of 267 leads with a mean implant duration of 9.8 years, including 90 defibrillator leads (33.7%), were targeted for extraction. No superior vena cava perforation or other vascular damage occurred. Clinical procedural success was achieved in 96.2% of cases. There were 5 major complications (3.8% of patients), with 3 being pericardial effusion requiring intervention. There were no deaths. CONCLUSION: A tandem femoral-superior approach to lead extraction effectively eliminated superior vena cava injury. This is a safe and effective technique for transvenous lead extraction.
Authors: B L Wilkoff; C L Byrd; C J Love; D L Hayes; T D Sellers; R Schaerf; V Parsonnet; L M Epstein; R A Sorrentino; C Reiser Journal: J Am Coll Cardiol Date: 1999-05 Impact factor: 24.094
Authors: Abhishek Deshmukh; Nileshkumar Patel; Peter A Noseworthy; Achint A Patel; Nilay Patel; Shilpkumar Arora; Suraj Kapa; Amit Noheria; Siva Mulpuru; Apurva Badheka; Avi Fischer; James O Coffey; Yong Mei Cha; Paul Friedman; Samuel Asirvatham; Juan F Viles-Gonzalez Journal: Circulation Date: 2015-11-03 Impact factor: 29.690
Authors: Mingyan Dai; David L Joyce; Shanda Blackmon; M P H Paul A Friedman; Raul Espinosa; Michael J Osborn; Congxin Huang; Yong-Mei Cha Journal: J Cardiovasc Electrophysiol Date: 2018-06-14
Authors: Oussama Wazni; Laurence M Epstein; Roger G Carrillo; Charles Love; Stuart W Adler; David W Riggio; Shahzad S Karim; Jamil Bashir; Arnold J Greenspon; John P DiMarco; Joshua M Cooper; John R Onufer; Kenneth A Ellenbogen; Stephen P Kutalek; Sherri Dentry-Mabry; Carolyn M Ervin; Bruce L Wilkoff Journal: J Am Coll Cardiol Date: 2010-02-09 Impact factor: 24.094
Authors: Jonas Keiler; Marko Schulze; Martina Sombetzki; Thomas Heller; Tina Tischer; Niels Grabow; Andreas Wree; Dietmar Bänsch Journal: J Cardiol Date: 2017-07 Impact factor: 3.159
Authors: Fred M Kusumoto; Mark H Schoenfeld; Bruce L Wilkoff; Charles I Berul; Ulrika M Birgersdotter-Green; Roger Carrillo; Yong-Mei Cha; Jude Clancy; Jean-Claude Deharo; Kenneth A Ellenbogen; Derek Exner; Ayman A Hussein; Charles Kennergren; Andrew Krahn; Richard Lee; Charles J Love; Ruth A Madden; Hector Alfredo Mazzetti; JoEllyn Carol Moore; Jeffrey Parsonnet; Kristen K Patton; Marc A Rozner; Kimberly A Selzman; Morio Shoda; Komandoor Srivathsan; Neil F Strathmore; Charles D Swerdlow; Christine Tompkins; Oussama Wazni Journal: Heart Rhythm Date: 2017-09-15 Impact factor: 6.343
Authors: Celso L Diaz; Xiaofan Guo; Isaac R Whitman; Gregory M Marcus; Cara N Pellegrini; Ramin E Beygui; Sun Yong Lee; Byron K Lee Journal: Europace Date: 2019-11-01 Impact factor: 5.214
Authors: Maria Grazia Bongiorni; Charles Kennergren; Christian Butter; Jean Claude Deharo; Andrzej Kutarski; Christopher A Rinaldi; Simone L Romano; Aldo P Maggioni; Maryna Andarala; Angelo Auricchio; Karl-Heinz Kuck; Carina Blomström-Lundqvist Journal: Eur Heart J Date: 2017-10-21 Impact factor: 29.983
Authors: Saumya Sharma; Byron K Lee; Anuj Garg; Robert Peyton; Brian T Schuler; Pamela Mason; Peter Paul Delnoy; Mark M Gallagher; Ramesh Hariharan; Raymond Schaerf; Ruirui Du; Nina D Serratore; Christoph T Starck Journal: Heart Rhythm O2 Date: 2021-03-02